drugset / Trial / NCT00333281

A Study of Visual Effects of Erectile Dysfunction Medications Dosed Daily for Six Months

NCT00333281

Phase 4 Completed 198 enrolled Eli Lilly and Company ICOS Corporation · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the effects on vision of six months of daily dosing of 5 mg tadalafil or 50 mg sildenafil compared with placebo.

Timeline

Start
2005-06
Primary completion
Completion
2006-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Tadalafil Small molecule 5 mg

Indications